4 assets in Pancreatic Intraductal Papillary-Mucinous Neoplasm

Therapeutic assets addressing Pancreatic Intraductal Papillary-Mucinous Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Secretin Pancreatic Intraductal Papillary-Mucinous Neoplasm	Fundacion Clinic per a la Recerca Biomédica	P3	B (60)
Sulindac Pancreatic Intraductal Papillary-Mucinous Neoplasm	Duke University	P2	CCC (53)
Vitamin E Delta Tocotrienol Pancreatic Intraductal Papillary-Mucinous Neoplasm	H. Lee Moffitt Cancer Center and Research Institute	P2	CCC (53)
ly4337713 Pancreatic Intraductal Papillary-Mucinous Neoplasm	Eli Lilly and Company	P1	NR ()